Author

Alison J. Latter

Observed names: A. Latter, Alison J Latter

Institution: GlaxoSmithKline (United Kingdom)

Observed institutions: University College Hospital, GlaxoSmithKline (United Kingdom), University Hospital of the West Indies, University College London, Medical Research Council

OpenAlex ID: A5063872136

Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ

1998 · Paul W. Young, Derek R. Buckle, et al. · Journal of Pharmacology and Experimental Therapeutics · 237

Characterization of [125I]‐SB‐258585 binding to human recombinant and native 5‐HT6 receptors in rat, pig and human brain tissue

2000 · Warren D Hirst, Jayne A L Minton, et al. · British Journal of Pharmacology · 120

Haemoglobin Synthesis in β‐Thalassaemia

1969 · C. B. Modell, A. Latter, et al. · British Journal of Haematology · 39

Rosiglitazone maleate (BRL 49653‐C); the preparation of [14C] and [3H] isotopomers

2001 · Tabassum Kirefu, Scott W Landvatter, et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 8

Reversible morphological changes in human breast fibroblasts exposed to stilboestrol

1978 · P.A. Riley, A. Latter, et al. · European Journal of Cancer (1965) · 4

Works count: 5

Citation count: 408

H-index: 4

I10-index: 3